Physician profile
Ghaith Aboud
NPI 1497117618
$1,147.52
in general payments reported to CMS, 2019-2025
12 companies · $944 in 2025
The $944 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.87 · 2023: $91.21 · 2024: $89.66 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $382.46 | 2024-2025 | Azure Xt Dr Mri Surescan, Linq II, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $217.11 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Gallant, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.15 | 2024-2025 | Lifevest |
| Stryker Corporation | $149.38 | 2025 | Flowtriever |
| Abiomed | $49.13 | 2025 | |
| Recor Medical INC | $45.01 | 2025 | Paradise Ultrasound Renal Denervation System |
| Edwards Lifesciences Corporation | $30.50 | 2025 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $25.84 | 2024 | Arcalyst |
| Mylan Specialty L.P. | $22.87 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.60 | 2025 | |
| Cardiva Medical, INC. | $21.18 | 2025 | Cardiva Vascade 6/7f Vcs |
| Terumo Medical Corporation | $17.29 | 2025 | Glidewire, Tr Band, Metacross Otw |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ghaith Aboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.